STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic...

Full description

Bibliographic Details
Main Authors: Linlin Zhang, Ping Xiao, Fanlu Meng, Diansheng Zhong
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/10/530
_version_ 1827650786138521600
author Linlin Zhang
Ping Xiao
Fanlu Meng
Diansheng Zhong
author_facet Linlin Zhang
Ping Xiao
Fanlu Meng
Diansheng Zhong
author_sort Linlin Zhang
collection DOAJ
description STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion.
first_indexed 2024-03-09T20:23:53Z
format Article
id doaj.art-01dc9935a300432694724fe03e35c66b
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T20:23:53Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-01dc9935a300432694724fe03e35c66b2023-11-23T23:39:36ZengMDPI AGCurrent Oncology1198-00521718-77292022-09-0129106749675310.3390/curroncol29100530STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case ReportLinlin Zhang0Ping Xiao1Fanlu Meng2Diansheng Zhong3Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, ChinaSTRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion.https://www.mdpi.com/1718-7729/29/10/530STRN-ALK fusionlung adenocarcinomabrain metastasisensartinib
spellingShingle Linlin Zhang
Ping Xiao
Fanlu Meng
Diansheng Zhong
STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
Current Oncology
STRN-ALK fusion
lung adenocarcinoma
brain metastasis
ensartinib
title STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_full STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_fullStr STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_full_unstemmed STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_short STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
title_sort strn alk fusion in lung adenocarcinoma with brain metastasis responded well to ensartinib a case report
topic STRN-ALK fusion
lung adenocarcinoma
brain metastasis
ensartinib
url https://www.mdpi.com/1718-7729/29/10/530
work_keys_str_mv AT linlinzhang strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT pingxiao strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT fanlumeng strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport
AT dianshengzhong strnalkfusioninlungadenocarcinomawithbrainmetastasisrespondedwelltoensartinibacasereport